Bafna Pharmaceuticals fundamental analysis
BAFNAPH
172.4
7.39 (4.48%)Last updated on 24 Dec, 2025 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Bafna Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
71.29
Sector P/B
1.09
Sec. Div. Yield
0.56
Bafna Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 71.29. Its P/B Ratio stands at 0, while the sector’s is 1.09. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Bafna Pharmaceuticals Score Card
Price
Attractive
Growth
Good
Quality
Average
Management
Average
On its scorecard, Bafna Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Average, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
